- Home
- Services
- latin america
- clinical screening trial
Refine by
Locations
- Latin America
- Antigua & Barbuda
- Argentina
- Aruba
- Bahamas
- Barbados
- Belize
- Bolivia
- Brazil
- Cayman Islands
- Chile
- Colombia
- Costa Rica
- Cuba
- Dominica
- Dominican Republic
- Ecuador
- El Salvador
- Grenada
- Guatemala
- Guyana
- Haiti
- Honduras
- Jamaica
- Mexico
- Netherlands Antilles
- Nicaragua
- Panama
- Paraguay
- Peru
- Puerto Rico
- St. Kitts & Nevis
- St. Lucia
- St. Vincent & The Grenadines
- Suriname
- Trinidad
- Uruguay
- Venezuela
Clinical Screening Trial Services In Latin America
4 services found
Manufactured by:Quantificare Inc. based inSuwanee, GEORGIA (US) (USA)
Over the past two decades, QuantifiCare has had the privilege of working with and establishing strong partnerships with numerous Key Opinion Leaders in core therapeutic ...
Manufactured by:Quantificare Inc. based inSuwanee, GEORGIA (US) (USA)
At QuantifiCare, our project team members come from varied backgrounds in clinical and scientific research. Our qualified staff consist of Imaging Specialists, Project Managers, Data Managers, Trainers, QA Specialists, all working together as a cross-functional team to understand your trial requirements and consult on the latest imaging techniques. We have developed both internal SOPs and ...
Manufactured by:Quantificare Inc. based inSuwanee, GEORGIA (US) (USA)
Our full line of standardized 2D and 3D cameras is indispensable achieving the level of image quality and reproducibility that ensure consistent and accurate clinical assessments. When combined with our advanced image analysis capabilities, we can provide endpoint support and analysis for all study phases. Our imaging data is generated in a validated format conformant with FDA, EMA and other ...
Manufactured by:Thermo Fisher Scientific based inWaltham, MASSACHUSETTS (USA)
Natural killer (NK) cells are innate lymphocytes that kill virally infected or malignant cells. Unlike T cells, NK cells function in an antigen independent manner, responding to anything they perceive as "non-self", including malignant cells. NK cells are an attractive allogeneic immune modulator, as they have a well-known safety profile and lack the potential to cause graft-vs-host disease, a ...